<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    INMODE LTD.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About INMODE LTD.

    InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $447,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Moshe Mizrahy
    • FOUNDED
      2008
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Accelerate Diagnostics, Inc.

    Accelerate Diagnostics, Inc.

    Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to provi...

    Accelerate Diagnostics, Inc. is an in vitro dia...

    Filing Type:    PU
    Repligen Corporation

    Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercia...

    Repligen Corporation is a global bioprocessing ...

    Filing Type:    PU
    Alternaturals, Inc.

    Alternaturals, Inc.

    Alternaturals, Inc. manufactures and sells alternative healthcare products includi...

    Alternaturals, Inc. manufactures and sells alte...

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    ICON plc

    ICON plc

    Since our foundation in Dublin, Ireland in 1990, our mission has been to help our ...

    Since our foundation in Dublin, Ireland in 1990...

    Filing Type:    PU
    Hancock Jaffe Laboratories, Inc.

    Hancock Jaffe Laboratories, Inc.

    HJLI specializes in developing and manufacturing bioprosthetic medical devices to ...

    HJLI specializes in developing and manufacturin...

    Filing Type:    PU
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    Second Sight Medical Products, Inc.

    Second Sight Medical Products, Inc.

    The recognized global leader in neuromodulation devices to treat blindness, the co...

    The recognized global leader in neuromodulation...

    Filing Type:    PU
    Royal Philips NV

    Royal Philips NV

    Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focuse...

    Royal Philips (NYSE: PHG, AEX: PHIA) is a leadi...

    Filing Type:    PU
    Medigus Ltd.

    Medigus Ltd.

    Medigus is a medical device company specializing in developing minimally invasive ...

    Medigus is a medical device company specializin...

    Filing Type:    PU
    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc. was born out of a collaborative research effort developing...

    Virtuoso Surgical, Inc. was born out of a colla...

    Filing Type:    RA
    Merit Medical Systems, Inc.

    Merit Medical Systems, Inc.

    Founded in 1987, Merit Medical set out to build the world’s most customer-focuse...

    Founded in 1987, Merit Medical set out to build...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.